BACKGROUND: To determine whether historic albuminuria measurements provide additional predictive value for diabetic end-stage renal disease (ESRD) and natural mortality over the most recent measurement, ie, whether "regression" from high albuminuria has a different prognosis than stability at the lower level. STUDY DESIGN: Observational longitudinal study. SETTING & PARTICIPANTS: Pima Indians 15 years or older with type 2 diabetes and at least 2 consecutive measurements of urinary albumin-creatinine ratio (ACR) within 6 years. PREDICTORS: Sequential measurements of urinary ACR. OUTCOMES & MEASUREMENTS: Proportional hazards analyses were used to estimate the risk of ESRD and natural death associated with the first and second ACR measurement. The ability of these highly correlated variables to predict outcome was compared with receiver operating characteristic curves calculated by means of the generalized c statistic. RESULTS: In 983 subjects, 136 developed ESRD and 180 died of natural causes during a maximum follow-up of 12.6 years. Each doubling in the second ACR was associated with a 1.71-fold greater incidence of ESRD (95% confidence interval, 1.54 to 1.89) and 1.16-fold greater natural mortality (95% confidence interval, 1.07 to 1.27) adjusted for age, sex, diabetes duration, and antihypertensive medication. The addition of the first ACR measurement to the model did not add to the predictive value for ESRD or mortality. In pairwise comparisons of c statistics, the second ACR was a significantly better predictor of ESRD than the first ACR. LIMITATIONS: The predictive value of ACR measurements is decreased to the extent that its precision is based on a single measure. CONCLUSION: The predictive power of the latest ACR for ESRD and natural mortality in patients with diabetes is not enhanced by knowledge of the preceding ACR. Therefore, ACR changes over time, ie, regression or progression, add minimal predictive value beyond the latest measurement in the series.
BACKGROUND: To determine whether historic albuminuria measurements provide additional predictive value for diabetic end-stage renal disease (ESRD) and natural mortality over the most recent measurement, ie, whether "regression" from high albuminuria has a different prognosis than stability at the lower level. STUDY DESIGN: Observational longitudinal study. SETTING & PARTICIPANTS: Pima Indians 15 years or older with type 2 diabetes and at least 2 consecutive measurements of urinary albumin-creatinine ratio (ACR) within 6 years. PREDICTORS: Sequential measurements of urinary ACR. OUTCOMES & MEASUREMENTS: Proportional hazards analyses were used to estimate the risk of ESRD and natural death associated with the first and second ACR measurement. The ability of these highly correlated variables to predict outcome was compared with receiver operating characteristic curves calculated by means of the generalized c statistic. RESULTS: In 983 subjects, 136 developed ESRD and 180 died of natural causes during a maximum follow-up of 12.6 years. Each doubling in the second ACR was associated with a 1.71-fold greater incidence of ESRD (95% confidence interval, 1.54 to 1.89) and 1.16-fold greater natural mortality (95% confidence interval, 1.07 to 1.27) adjusted for age, sex, diabetes duration, and antihypertensive medication. The addition of the first ACR measurement to the model did not add to the predictive value for ESRD or mortality. In pairwise comparisons of c statistics, the second ACR was a significantly better predictor of ESRD than the first ACR. LIMITATIONS: The predictive value of ACR measurements is decreased to the extent that its precision is based on a single measure. CONCLUSION: The predictive power of the latest ACR for ESRD and natural mortality in patients with diabetes is not enhanced by knowledge of the preceding ACR. Therefore, ACR changes over time, ie, regression or progression, add minimal predictive value beyond the latest measurement in the series.
Authors: T H Jafar; P C Stark; C H Schmid; M Landa; G Maschio; C Marcantoni; P E de Jong; D de Zeeuw; S Shahinfar; P Ruggenenti; G Remuzzi; A S Levey Journal: Kidney Int Date: 2001-09 Impact factor: 10.612
Authors: Ramachandran S Vasan; Joseph M Massaro; Peter W F Wilson; Sudha Seshadri; Philip A Wolf; Daniel Levy; Ralph B D'Agostino Journal: Circulation Date: 2002-01-01 Impact factor: 29.690
Authors: R Nosadini; M Velussi; E Brocco; M Bruseghin; C Abaterusso; A Saller; M Dalla Vestra; A Carraro; E Bortoloso; M Sambataro; I Barzon; F Frigato; B Muollo; M Chiesura-Corona; G Pacini; B Baggio; F Piarulli; A Sfriso; P Fioretto Journal: Diabetes Date: 2000-03 Impact factor: 9.461
Authors: Bruce A Perkins; Linda H Ficociello; Kristen H Silva; Dianne M Finkelstein; James H Warram; Andrzej S Krolewski Journal: N Engl J Med Date: 2003-06-05 Impact factor: 91.245
Authors: Meda E Pavkov; William C Knowler; Kevin V Lemley; Clinton C Mason; Bryan D Myers; Robert G Nelson Journal: Clin J Am Soc Nephrol Date: 2011-11-10 Impact factor: 8.237
Authors: Ron T Gansevoort; Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh Journal: Kidney Int Date: 2011-02-02 Impact factor: 10.612
Authors: Amy K Mottl; Adil Gasim; Fernanda Payan Schober; Yichun Hu; Askia K Dunnon; Susan L Hogan; J Charles Jennette Journal: J Am Soc Nephrol Date: 2017-11-27 Impact factor: 10.121
Authors: Roland E Schmieder; Johannes F E Mann; Helmut Schumacher; Peggy Gao; Giuseppe Mancia; Michael A Weber; Matthew McQueen; Teo Koon; Salim Yusuf Journal: J Am Soc Nephrol Date: 2011-06-30 Impact factor: 10.121
Authors: Gudeta D Fufaa; E Jennifer Weil; Robert G Nelson; Robert L Hanson; Joseph V Bonventre; Venkata Sabbisetti; Sushrut S Waikar; Theodore E Mifflin; Xiaoming Zhang; Dawei Xie; Chi-Yuan Hsu; Harold I Feldman; Josef Coresh; Ramachandran S Vasan; Paul L Kimmel; Kathleen D Liu Journal: Diabetologia Date: 2014-10-15 Impact factor: 10.122
Authors: Brad P Dieter; Sterling M McPherson; Maryam Afkarian; Ian H de Boer; Rajnish Mehrotra; Robert Short; Celestina Barbosa-Leiker; Radica Z Alicic; Rick L Meek; Katherine R Tuttle Journal: J Diabetes Complications Date: 2016-07-27 Impact factor: 2.852
Authors: Daniel E Weiner; Maria Krassilnikova; Hocine Tighiouart; Deeb N Salem; Andrew S Levey; Mark J Sarnak Journal: BMC Nephrol Date: 2009-09-17 Impact factor: 2.388